Hanna Bayer
Albert Einstein Allee 11
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease.
Journal: Neurochemistry international
Published: March 25, 2017
Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease.
Journal: Scientific reports
Published: February 21, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.
Journal: Frontiers in molecular neuroscience
Published: February 06, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
Journal: Neuropharmacology
Published: November 29, 2016
Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
Journal: Acta neuropathologica
Published: October 20, 2015
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.
Journal: Acta neuropathologica
Published: June 25, 2015
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
Journal: Annals of neurology
Published: March 06, 2014
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis.
Journal: Human molecular genetics
Published: May 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026